Genomic Medicine: PersonalizedTherapeutics Based on Genetic Profiling

Abstract

The study examines whether it is suitable and helpful to treat conditions such as hypertension, Type 2 diabetes and breast cancer using personalized ways based on a person’s genes. With a mixed-methods study, researchers assigned 120 patients to the treatment group and control group to observe the difference between genetic therapies and standard treatment options. The quantitative part looked at things like patients’ vital signs, real outcomes from using the drugs, drug-related side effects and how pleased patients were with their care. The qualitative look was based on interviews with health professionals. It was shown that patients who got personalized care improved in ways such as reduced blood pressure, decreased HbA1c and bigger tumor shrinkage and they had fewer adverse reaction risks and felt more satisfied. The analysis of statistics showed that the genetic markers CYP2C9 and BRCA1 are significant for predicting cancer development. This research shows clear evidence that using genomics in medicine is helpful and helps bring theoretical ideas to practice. The importance of having good infrastructure, strong policies and the use of various types of genomic information is underlined for broader implementation of precision medicine.